MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202538029975 A) filed by Vertex Pharmaceuticals Incorporated, Boston, on March 28, for 'modulators of cystic fibrosis transmembrane conductance regulator.'
Inventor(s) include Miller, Mark Thomas; Anderson, Corey; Arumugam, Vijayalaksmi; Bear, Brian Richard; Binch, Hayley Mariean; Clemens, Jeremy J; Cleveland, Thomas; Conroy, Erica; Coon, Timothy Richard; Frieman, Bryan A.; Grootenhuis, Peter Diederik Jan; Gross, Raymond Stanley; Hadida-Ruah, Sara Sabina; Khatuya, Haripada; Joshi, Pramod Virupax; Krenitsky, Paul John; Lin, Chun-Chieh; Marelius, Gulin Erdogan; Melillo, Vito; Mccartney, Jason; Nicholls, Georgia Mcgaughey; Pierre, Fabrice Jean Denis; Silina, Alina; Termin, Andreas P.; Uy, Johnny; and Zhou, Jinglan.
The application for the patent was published on June 27, under issue no. 26/2025.
According to the abstract released by the Intellectual Property India: "The present invention features a compound of formula (I): (I) or a pharmaceutically acceptable salt thereof, where R1, R2, R3, W, X, Y, Z, n, o, p, and q are defined herein, for the treatment of CFTR mediated diseases, such as cystic fibrosis. The present invention also features pharmaceutical compositions, method of treating, and kits thereof."
The patent application was internationally filed on Oct. 06, 2015, under International application No.PCT/US2015/054316.
Disclaimer: Curated by HT Syndication.
